References
- Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–1068.
- Bornstein J, Preti M, Simon JA, et al. Descriptors of vulvodynia: a multisocietal definition consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society). J Low Genit Tract Dis. 2019;23(2):161–163.
- Available from: http://cebgrade.mcmaster.ca/
- Song YB, Hwang K, Kim DJ, et al. Innervation of vagina: microdissection and immunohistochemical study. J Sex Marital Ther. 2009;35(2):144–153.
- Lewis FM. Vulval symptoms after the menopause - not all atrophy!! Post Reprod Health. 2015;21(4):146–145.
- Binder RL, Freedman MA, Sharma KB, et al. Histological and gene expression analysis of the effects of menopause status and hormone therapy on the vaginal introitus and labia majora. J Clin Med Res. 2019;11(11):745–759.
- Comino R, Coronado PJ, Cararach M, et al. Spanish consensus on vulvar disorders in postmenopausal women. Maturitas. 2015;80(2):226–233.
- Freynhagen R, Arevalo Parada H, Calderon-Ospina CA, et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin. 2019;35(6):1011–1088.
- Palacios S, Castelo-Branco C, Currie H, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas. 2015;82(3):308–313.
- Rosen N, Bergeron S, Pukall CF. Recommendations for the study of vulvar pain in women, part 1: review of assessment tools. J Sex Med. 2020;17(2):180–194.
- Stewart EG, Bissonnette I, Margesson LJ, et al. Vulvovaginal disorders. 2014. Available from: https://vulvovaginaldisorders.com
- Jannini EA, Nappi RE. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sex Med Rev. 2018;6(3):384–395.
- Thomas HM, Bryce CL, Ness RB, et al. Dyspareunia is associated with decreased frequency of intercourse in the menopausal transition. Menopause. 2011;18(2):152–157.
- Sanchez-Borrego R, Molero F, Castaño R, et al. Spanish consensus on sexual health in men and women over 50. Maturitas. 2014; 78(2):138–145.
- Bornstein J, Goldstein AT, Stockdale CK, et al. Consensus vulvar pain terminology committee of the International Society for the Study of Vulvovaginal Disease (ISSVD); International Society for the Study of Women's Sexual Health (ISSWSH); International Pelvic Pain Society (IPPS). 2015 ISSVD, ISSWSH, and IPPS Consensus terminology and classification of persistent vulvar pain and vulvodynia. J Sex Med. 2016;13(04):607–612.
- Basson R. Sexual function of women with chronic illness and cancer. Womens Health (Lond). 2010;6(3):407–429.
- Kao A, Binik YM, Amsel R, et al. Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment. J Sex Med. 2012;9(8):2066–2076.
- Nappi RE, Mattsson LÅ, Lachowsky M, et al. The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe. Maturitas. 2013;75(4):373–379.
- Anderson AB, Rosen NO, Price L, et al. Associations between penetration cognitions, genital pain, and sexual well-being in women with provoked vestibulodynia. J Sex Med. 2016;13(3):444–452.
- Palacios S. Managing urogenital atrophy. Maturitas. 2009;63(4):315–318.
- Reed BD, Plegue MA, Harlow SD, et al. Does degree of vulvar sensitivity predict vulvodynia characteristics and prognosis? J Pain. 2017;18(2):113–123.
- Shafik A, El Sibai O, Shafik AA, et al. The electrovaginogram: study of the vaginal electric activity and its role in the sexual act and disorders. Arch Gynecol Obstet. 2004;269(4):282–286.
- Shafik A. Study of the uterine response to vaginal distension: the 'vagino-uterine reflex. Gynecol Obstet Invest. 1997;44(4):265–269.
- Palacios MJ, Cancelo C, Castelo Branco P, et al. Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions. Climacteric. 2017;20(1):55–61,
- Micheletti L, Bogliatto F, Lynch PJ. Vulvoscopy: review of a diagnostic approach requiring clarification. J Reprod Med. 2008;53(3):179–182.
- Nappi RE, Graziottin A, Mollaioli D, et al. The gynogram: a multicentric validation of a new psychometric tool to assess coital pain associated with VVA and its impact on sexual quality of life in menopausal women. J Sex Med. 2021;18(5):955–965.
- Nappi RE, Di Carlo C, Cucinella L, et al. Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/genitourinary syndrome of menopause (GSM) through the estro-androgenic lens - Cluster analysis of a web-based Italian survey among women over 40. Maturitas. 2020;140:72–79.
- Potter N, Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric. 2021;24(1):19–24.
- Davis SR, Baber R, Panay N, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660–4666.
- Goldstein S, Minton J, Gagnon C, et al. Open-label pilot, prospective vulvoscopic study of daily administration of prasterone vaginal inserts in women with moderate to severe dyspareunia. J Sex Med. 2020;17(1):S8–S9.
- Nohales F, Duarte M, Vazquez S, et al. Bas E eficacia de la combinación de estrógenos y andrógenos locales en el tratamiento del dolor vulvar asociado al síndrome genitourinario de la menopausia. Toko-Gin Pract. 2020;79(3):120–126.
- Alvisi S, Baldassarre M, Gava G, et al. Structure of epithelial and stromal compartments of vulvar and vaginal tissue from women with Vulvo-Vaginal atrophy taking ospemifene. J Sex Med. 2018;15(12):1776–1784.
- Goldstein SR, Bachmann GA, Koninckx PR, et al. Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy. Climacteric. 2014;17(2):173–182.
- Murina F, Di Francesco S, Oneda S. Vulvar vestibular effects of ospemifene: a pilot study. Gynecol Endocrinol. 2018;34(7):631–635.
- Goldstein I, Simon JA, Kaunitz AM, et al. Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices. Menopause. 2019;26(9):994–1001.
- Goldstein SW, Winter AG, Goldstein I. Improvements to the vulva, vestibule, urethral meatus, and vagina in women treated with ospemifene for moderate to severe dyspareunia: a prospective vulvoscopic pilot study. Sex Med. 2018;6:154–161.
- Murina F, Karram M, Salvatore S, et al. Fractional CO2 laser treatment of the vestibule for patients with vestibulodynia and genitourinary syndrome of menopause: a pilot study. J Sex Med. 2016;13(12):1915–1917.
- Murina F, Felice R, Di Francesco S, et al. Ospemifene plus fractional CO2 laser: a powerful strategy to treat postmenopausal vulvar pain. Gynecol Endocrinol. 2020;36(5):431–435.
- Baquedano L, Sánchez S, Aznar T, et al. Síndrome genitourinario de la menopausia, MenoGuía AEE. Primera edición. 2020. ISBN: 978-84-338-6693-6. DL: Gr/693-2020. Editorial Universidad de Granada.